Stanford, California 94305

  • Hodgkin's Disease

Purpose:

The purpose of this study is to characterize the molecular and cell biology of the tumor cells in lymphoma.


Study summary:

This research involves the study of lymphoma cells in order to better understand how the disease grows and spreads. This study may lead to the development of special materials that could be used, in the future, to treat lymphoma or to follow the response of lymphoma to treatment.


Criteria:

Inclusion Criteria: - Diagnosis of Hodgkin's disease or non-Hodgkin's lymphoma, any cellular classification, any stage, any grade. - Adult or pediatric patients receiving lymph node excision for purposes other than cancer therapy (i.e. tonsillectomy, sleep apnea). - A routine procedure for tissue collection is planned. - Ability to understand and the willingness to sign a written informed consent. Exclusion Criteria: - Patients without NHL or Hodgkin's disease


NCT ID:

NCT00398177


Primary Contact:

Principal Investigator
Ronald Levy, MD
Stanford University

Ami Okada
Phone: 650-725-4968
Email: amio@stanford.edu


Backup Contact:

N/A


Location Contact:

Stanford, California 94305
United States

Ami Okada
Phone: 650-725-4968
Email: amio@stanford.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: September 27, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.